We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

State-of-the-Art, Non-Invasive Ultrasound Technology Identifies Patients with Advanced Chronic Liver Disease

By MedImaging International staff writers
Posted on 09 Mar 2022
Print article
Image: FibroScan GO (Photo courtesy of Echosens)
Image: FibroScan GO (Photo courtesy of Echosens)

An affordable, cost-effective tool uses ultrasound technology for screening liver health, improving liver health management at the point of care for primary care practices and reducing the flow of patients in secondary care centers.

Echosens (France, Paris) has launched FibroScan GO, a state-of-the-art, non-invasive solution for identifying patients with advanced chronic liver disease. FibroScan GO is a solution for quickly and easily assessing liver stiffness using LSM by VCTE and CAP for liver fibrosis and steatosis assessment and management among patients with, or suspected of having, liver fibrosis and cirrhosis.

Chronic liver disease is a public health crisis that affects 1.9 billion people worldwide and accounts for two million deaths per year. The main causes of chronic liver disease include nonalcoholic fatty liver disease (NAFLD) and its more severe form non-alcoholic steatohepatitis (NASH), alcohol and viral hepatitis. FibroScan GO is designed for use in a medical practice in order to provide liver stiffness measurement at 50 Hz shear wave frequency and liver ultrasonic attenuation (CAP) at 3.5 MHz ultrasound frequency. It enables operators to screen at-risk patients for early intervention and diagnosis, patient stratification and monitoring of disease progression.

FibroScan GO integrates instantly into an office-based practice with small footprint and connectivity, acting as smaller, mobile equipment for easy integration outside of secondary care. It offers enhanced clinical decision support with the Interpretation Guide and Scores by Echosens available on the myFibroScan app. It is integrated with Echosens Cloud for centralized and secure data management. The fast, simple and non-invasive examination can be performed by any trained operator, including healthcare practitioner or nurse. The test is repeatable and reproducible and offers consistent results.

“Primary care practices can now manage and monitor at-risk patients and make an early diagnosis, which is essential for halting or reversing liver disease,” said Dominique Legros, Group CEO, Echosens. “FibroScan GO is a powerful tool for the prognosis of disease course, enabling immediate medical decisions for improved patient outcomes and higher healthcare efficiency.”

“Echosens is bringing greater peace of mind with FibroScan GO’s proactive and dedicated support team who assist with onsite installation and training. With a flexible and affordable pay per exam offer, this tool not only reduces referrals to secondary care, but also obviates the need for capital investment to achieve an early liver disease diagnosis that reduces the cost of liver-related illness,” added Legros.

Related Links:

Print article



view channel
Image: Spinal fractures in the elderly are preventable with simple X-rays (Photo courtesy of Pexels)

Simple X-Ray Method Can Diagnose Vertebral Compression and Prevent Spinal Fractures

Vertebral compression means that the spine is compressed, causing a fracture in one of the vertebrae. Vertebral compression fractures (VCFs) occur easily in people with osteoporosis and are very common... Read more

Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: RSNA`s annual meeting is the world`s largest medical imaging conference (Photo courtesy of RSNA)

RSNA 2022 Sees Rise in Abstract Submissions Ahead of Annual Meeting

The Radiological Society of North America (RSNA, Oak Brook, IL, USA) has announced that nearly 10,400 scientific and educational abstracts have been submitted for the Society's 108th Scientific Assembly... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.